Otsuka Pharm Co Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for OTSUKA PHARM CO LTD, and when can generic versions of OTSUKA PHARM CO LTD drugs launch?
OTSUKA PHARM CO LTD has one approved drug.
There are twelve US patents protecting OTSUKA PHARM CO LTD drugs.
There are two hundred and sixteen patent family members on OTSUKA PHARM CO LTD drugs in thirty-eight countries and twelve supplementary protection certificates in eleven countries.
Summary for Otsuka Pharm Co Ltd
| International Patents: | 216 |
| US Patents: | 12 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Otsuka Pharm Co Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Otsuka Pharm Co Ltd | ABILIFY MAINTENA KIT | aripiprazole | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 202971-003 | Sep 29, 2014 | RX | Yes | No | 9,089,567 | See Plans and Pricing | See Plans and Pricing | ||||
| Otsuka Pharm Co Ltd | ABILIFY MAINTENA KIT | aripiprazole | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 202971-002 | Feb 28, 2013 | RX | Yes | Yes | 10,980,803 | See Plans and Pricing | See Plans and Pricing | ||||
| Otsuka Pharm Co Ltd | ABILIFY MAINTENA KIT | aripiprazole | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 202971-004 | Sep 29, 2014 | RX | Yes | No | 10,525,057 | See Plans and Pricing | See Plans and Pricing | ||||
| Otsuka Pharm Co Ltd | ABILIFY MAINTENA KIT | aripiprazole | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 202971-003 | Sep 29, 2014 | RX | Yes | No | 7,807,680 | See Plans and Pricing | Y | See Plans and Pricing | |||
| Otsuka Pharm Co Ltd | ABILIFY MAINTENA KIT | aripiprazole | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 202971-001 | Feb 28, 2013 | RX | Yes | No | 7,807,680 | See Plans and Pricing | Y | See Plans and Pricing | |||
| Otsuka Pharm Co Ltd | ABILIFY MAINTENA KIT | aripiprazole | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 202971-004 | Sep 29, 2014 | RX | Yes | No | 11,154,553 | See Plans and Pricing | See Plans and Pricing | ||||
| Otsuka Pharm Co Ltd | ABILIFY MAINTENA KIT | aripiprazole | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 202971-003 | Sep 29, 2014 | RX | Yes | No | 8,993,761 | See Plans and Pricing | Y | See Plans and Pricing | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Otsuka Pharm Co Ltd
International Patents for Otsuka Pharm Co Ltd Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Poland | 393607 | See Plans and Pricing |
| China | 103288727 | See Plans and Pricing |
| Slovenia | 1419776 | See Plans and Pricing |
| China | 104306374 | See Plans and Pricing |
| Georgia, Republic of | P20115205 | See Plans and Pricing |
| Malaysia | 138669 | See Plans and Pricing |
| Portugal | 1925308 | See Plans and Pricing |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Otsuka Pharm Co Ltd Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1675573 | 92427 | Luxembourg | See Plans and Pricing | PRODUCT NAME: ARIPIPRAZOLE |
| 1675573 | CA 2014 00026 | Denmark | See Plans and Pricing | PRODUCT NAME: ARIPIPRAZOL; REG. NO/DATE: EU/1/13/882/001-004 20131119 |
| 1675573 | PA2014020 | Lithuania | See Plans and Pricing | PRODUCT NAME: ARIPIPRAZOLUM; REGISTRATION NO/DATE: EU/1/13/882 20131115 |
| 1675573 | C20140014 00322 | Estonia | See Plans and Pricing | PRODUCT NAME: ARIPIPRASOOL;REG NO/DATE: K(2013)8163 (LOPLIK) 19.11.2013 |
| 1675573 | 300669 | Netherlands | See Plans and Pricing | PRODUCT NAME: ARIPIPRAZOLE; REGISTRATION NO/DATE: EU/1/13/882 20131115 |
| 1675573 | C01675573/01 | Switzerland | See Plans and Pricing | PRODUCT NAME: ARIPIPRAZOL; REGISTRATION NO/DATE: SWISSMEDIC 63177 28.04.2014 |
| 1675573 | 32/2014 | Austria | See Plans and Pricing | PRODUCT NAME: ARIPIPRAZOL; REGISTRATION NO/DATE: EU/1/13/882 (MITTEILUNG) 20131119 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
